Both in Pharmaceuticals
BioMarin Pharmaceuticals vs Summit Therapeutics
Over the past year BMRN returned +7.2% and SMMT returned −12.0%; their daily moves had a correlation of 0.23.
BMRN +7.2% SMMT −12.0%Growth of $1, one year, split-adjusted
| Metric | BMRN | SMMT |
|---|---|---|
| Price | $56.65 | $16.04 |
| Market cap | $10.97B | $12.80B |
| Today | +1.78% | +1.52% |
| 1 month | +0.8% | −7.3% |
| 6 months | +3.8% | −10.1% |
| Year to date | −4.7% | −8.3% |
| 1 year | +7.2% | −12.0% |
| Revenue growth (YoY) | +19.9% | — |
| Gross margin | 79.5% | — |
| Net margin | 4.5% | — |
| P/E (TTM) | 150.3× | — |
| Price / sales | 3.2× | — |
| Net cash | -$3.31B | $690.7M |
| Dividend yield | — | — |
| Volatility (60d) | 26.9% | 70.7% |
| Short % of float | 6.2% | 29.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).